Rowan Zyada (@rowanzyada) 's Twitter Profile
Rowan Zyada

@rowanzyada

Adult Nephrologist, NSMC 2024 intern, Associate alumni Harvard Medical School

ID: 1499832591272353792

calendar_today04-03-2022 19:42:59

152 Tweet

81 Takipçi

188 Takip Edilen

CASTAWAYS (@flowcastaways) 's Twitter Profile Photo

Proud enough the #NephJC Manuscript of the Year 2024 award was for the breakthrough paper in the NEJM: Effects of Semaglutide in Chronic Kidney Disease Patients with Type 2 Diabetes. Check the nice summary by Neal Shah pod mates Rowan Zyada Sejal Lakhani, DO nephjc.com/news/flow?rq=F…

Proud enough the #NephJC Manuscript of the Year 2024 award was for the breakthrough paper in the NEJM:  Effects of Semaglutide in Chronic Kidney Disease Patients with Type 2 Diabetes.
Check the nice summary by <a href="/NSMC/">Neal Shah</a> pod mates <a href="/RowanZyada/">Rowan Zyada</a> <a href="/sejalplakhani/">Sejal Lakhani, DO</a> 
nephjc.com/news/flow?rq=F…
CASTAWAYS (@flowcastaways) 's Twitter Profile Photo

The choice of best #NephJC 2024 manuscript matches up nicely with our #NephMadness 2024 winner, Gila The NephMadness Monster, the mother of GLP1 antagonists. celebrate #glipinators ajkdblog.org/2024/03/01/nep…

CASTAWAYS (@flowcastaways) 's Twitter Profile Photo

1/ 🚨Welcome to #castaways Neal Shah pod2 interns tweetorial on the magic metabolic pill 💊 #GLP_1RA #glipinators #FLOW_with_castaways

PraveenG (@nephtales) 's Twitter Profile Photo

10 Myths about furosemide #1 causes AKI. No, it does not. #2 Frusemide and fluids together can prevent AKI in high-risk patients. Probably not. #3 Contraindicated in AKI. No, it is not. #4 Can kick-start kidney function. No, this is not the case. 1/3 #nephtwitter #MedX

10 Myths about furosemide 

#1  causes AKI. No, it does not.

#2 Frusemide and fluids together can prevent AKI in high-risk patients. Probably not.

#3 Contraindicated in AKI. No, it is not.

#4 Can kick-start kidney function. No, this is not the case.

1/3
#nephtwitter 
#MedX
CASTAWAYS (@flowcastaways) 's Twitter Profile Photo

Is the 4th pillar now available⁉️ 👉Till 2019: RAASi are prescribed for nephroprotection in #DKD 👉In 2019, #CREDENCE trial: renal benefits of SGLT2i 👉In 2020, #Finerenone⬇️risk of CKD progression in patients with T2D 👉In 2024, #FLOW trial: #Semaglutide⬇️#CKD progression in T2D

Is the 4th pillar now available⁉️
👉Till 2019: RAASi are prescribed for nephroprotection in #DKD
👉In 2019, #CREDENCE trial: renal benefits of SGLT2i
👉In 2020, #Finerenone⬇️risk of CKD progression in patients with T2D
👉In 2024, #FLOW trial: #Semaglutide⬇️#CKD progression in T2D
CASTAWAYS (@flowcastaways) 's Twitter Profile Photo

💡 Tip 6: #GLP1RA therapy is excellent for weight reduction in diabetic patients. #Obesity #Diabetes #Nephpearls #NephTwitter

💡 Tip 6: #GLP1RA therapy is excellent for weight reduction in diabetic patients. #Obesity #Diabetes #Nephpearls #NephTwitter
CASTAWAYS (@flowcastaways) 's Twitter Profile Photo

💡 Tip 9: #GLP1RAs can improve glycemic control without increasing hypoglycemia risk in #CKD patients, a major advantage over other diabetes medications. #NephTwitter #Nephpearls

💡 Tip 9: #GLP1RAs can improve glycemic control without increasing hypoglycemia risk in #CKD patients, a major advantage over other diabetes medications. #NephTwitter #Nephpearls
CASTAWAYS (@flowcastaways) 's Twitter Profile Photo

💡 Tip 10: though bunch of benefits, #GLP1RA have also some cons. Use with caution🚨 #Nephpearls #NephTwitter #Flow_trial

💡 Tip 10: though bunch of benefits, #GLP1RA have also some cons. Use with caution🚨 
#Nephpearls #NephTwitter #Flow_trial
Edgar V. Lerma 🇵🇭 (@edgarvlermamd) 's Twitter Profile Photo

The 2025 Clinical Practice Guideline for the Anemia in CKD from KDIGO is out for public review ‼️ #KDIGOAnemiainCKD #Nephpearls 📌 Submit comments by Nov 22 🗓️ 👉 kdigo.org/guidelines/ane…

The 2025 Clinical Practice Guideline for the Anemia in CKD from <a href="/goKDIGO/">KDIGO</a> is out for public review ‼️ 
#KDIGOAnemiainCKD #Nephpearls 

📌 Submit comments by Nov 22 🗓️

👉 kdigo.org/guidelines/ane…
Tony Breu (@tony_breu) 's Twitter Profile Photo

Here are 10 randomized trials I'd love to see (share links if they've been done!): 1. Potassium repletion to >4.0 vs 3.5 or 3.0 in hospitalized medical patients 2. Treatment vs observation for hypertensive urgency 3. Iron supplementation (likely IV) vs placebo for anemia of

Joel M. Topf, MD FACP (@kidney_boy) 's Twitter Profile Photo

Honey, stop what you're doing, new hyponatremia research just dropped! What's it say? It looks like slow correction is associated with worse outcomes, like death and length of stay! Was it just a small study? No, it was a meta-analysis of almost 12,000 patients!

أحمد السيد (@ahmadyusufals) 's Twitter Profile Photo

الله أكبر الله أكبر الله أكبر .. ولله الحمد لا إله إلا الله وحده صدق وعده ونصر عباده وهزم الأحزاب وحده، لله الحمد لله الحمد لله الحمد .. #حماة تتحرر "وتم تحرير الأسرى من سجن حماة المركزي" وهذه الجملة تستحق كل جهد بذل وكل دماء قدمت وكل تعب وعرق ونصب.. والعقبى لبقية الأسرى

أحمد السيد (@ahmadyusufals) 's Twitter Profile Photo

إي والله.. هذا نصر الله .. ومسكين من لا يراه.. ومغبون من لم يفهم سننه وآياته المتحققة في هذا الفتح.. الله أكبر يا ربنا لك الحمد.. اللهم وارض عن عبادك الذين بذلوا وضحوا وصبروا وثبتوا وأقدموا.. اللهم ضاعف لهم الحسنات. اللهم وأتم علينا النعمة بالفتح وبعلو كلمتك. وأما من اسودّ وجهه

أحمد السيد (@ahmadyusufals) 's Twitter Profile Photo

غزّة وأهلها في بلاء شديد وكرب عظيم، ومجرمو الكيان المحتلّ يقتِّلون ويهدمون ويُفسدون ويحرقون ويستهدفون المستشفيات والأطفال والنازحين أمام جميع العالم استكباراً وبطراً وطغياناً. واشتدّ على إخواننا البلاء والبرد والغلاء والفقد والأسر والتشريد والنزوح. ومن يعش منّا فسيرى انتقام الله